VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q47696604 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010713.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q47696604‏
024 ‎‡a 0000-0003-2212-3899‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q47696604‏
100 0 ‎‡a Thiago Moreno L Souza‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Thiago Moreno L Souza‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Thiago Moreno L Souza‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.‏
670 ‎‡a Author's 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine‏
670 ‎‡a Author's An observational clinical case of Zika virus-associated neurological disease is associated with primary IgG response and enhanced TNF levels.‏
670 ‎‡a Author's Anti HSV-1 Alkaloids from a Feeding Deterrent Marine Sponge of the Genus Aaptos‏
670 ‎‡a Author's Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A‏
670 ‎‡a Author's Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A (H1N1) resistance to oseltamivir.‏
670 ‎‡a Author's Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production‏
670 ‎‡a Author's Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production‏
670 ‎‡a Author's Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin‏
670 ‎‡a Author's Capturing sequence diversity in metagenomes with comprehensive and scalable probe design‏
670 ‎‡a Author's Characterization of HIV-1 enzyme reverse transcriptase inhibition by the compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid through kinetic and in silico studies‏
670 ‎‡a Author's Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil, 2015‏
670 ‎‡a Author's Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture‏
670 ‎‡a Author's Correction: Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin‏
670 ‎‡a Author's Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication‏
670 ‎‡a Author's Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs‏
670 ‎‡a Author's Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out?‏
670 ‎‡a Author's Detection of the influenza A(H1N1)pdm09 virus carrying the K-15E, P83S and Q293H mutations in patients who have undergone bone marrow transplant‏
670 ‎‡a Author's Detection of Zika Virus in April 2013 Patient Samples, Rio de Janeiro, Brazil‏
670 ‎‡a Author's Development of standard methods for Zika virus propagation, titration, and purification‏
670 ‎‡a Author's Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil‏
670 ‎‡a Author's H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis‏
670 ‎‡a Author's H1N1pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two single versus two double doses.‏
670 ‎‡a Author's Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase‏
670 ‎‡a Author's Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase (PFK-1).‏
670 ‎‡a Author's HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion‏
670 ‎‡a Author's HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection‏
670 ‎‡a Author's Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology‏
670 ‎‡a Author's Identification of 1-Aryl-1H-1,2,3-triazoles as Potential New Antiretroviral Agents‏
670 ‎‡a Author's Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine‏
670 ‎‡a Author's Influenza virus RNA polymerase may be activated inside the virion‏
670 ‎‡a Author's Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone‏
670 ‎‡a Author's Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity‏
670 ‎‡a Author's Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice‏
670 ‎‡a Author's Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators‏
670 ‎‡a Author's Molecular findings from influenza A‏
670 ‎‡a Author's Molecular findings from influenza A(H1N1)pdm09 detected in patients from a Brazilian equatorial region during the pandemic period.‏
670 ‎‡a Author's N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity‏
670 ‎‡a Author's New efavirenz derivatives and 1,2,3-triazolyl-phosphonates as inhibitors of reverse transcriptase of HIV-1‏
670 ‎‡a Author's Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19‏
670 ‎‡a Author's Polymorphisms at residue 222 of the hemagglutinin of pandemic influenza A(H1N1)pdm09: association of quasi-species to morbidity and mortality in different risk categories‏
670 ‎‡a Author's Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.‏
670 ‎‡a Author's SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine series.‏
670 ‎‡a Author's Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae‏
670 ‎‡a Author's Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives‏
670 ‎‡a Author's Synthesis and anti-HSV-1 evaluation of new 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines and 3H-pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridines‏
670 ‎‡a Author's Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives‏
670 ‎‡a Author's The alkaloid 4-methylaaptamine isolated from the sponge Aaptos aaptos impairs Herpes simplex virus type 1 penetration and immediate-early protein synthesis‏
670 ‎‡a Author's The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication‏
670 ‎‡a Author's The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase‏
670 ‎‡a Author's The dolabellane diterpene Dolabelladienetriol is a typical noncompetitive inhibitor of HIV-1 reverse transcriptase enzyme‏
670 ‎‡a Author's The effects of neurotrophins and the neuropeptides VIP and PACAP on HIV-1 infection: histories with opposite ends‏
670 ‎‡a Author's The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages.‏
670 ‎‡a Author's Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo‏
909 ‎‡a (orcid) 0000000322123899‏ ‎‡9 1‏
919 ‎‡a designsynthesisandantiviralactivityofnew1h123triazolenucleosideribavirinanalogs‏ ‎‡A Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs‏ ‎‡9 1‏
919 ‎‡a 123triazolyl4oxoquinolinesafeasiblebeginningforpromisingchemicalstructurestoinhibitoseltamivirresistantinfluenzaaandbviruses‏ ‎‡A 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.‏ ‎‡9 1‏
919 ‎‡a 28bistrifluoromethylquinolineanalogsshowimprovedantizikavirusactivitycomparedtomefloquine‏ ‎‡A 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine‏ ‎‡9 1‏
919 ‎‡a observationalclinicalcaseofzikavirusassociatedneurologicaldiseaseisassociatedwithprimaryiggresponseandenhancedtnflevels‏ ‎‡A An observational clinical case of Zika virus-associated neurological disease is associated with primary IgG response and enhanced TNF levels.‏ ‎‡9 1‏
919 ‎‡a antihsv1alkaloidsfromafeedingdeterrentmarinespongeofthegenusaaptos‏ ‎‡A Anti HSV-1 Alkaloids from a Feeding Deterrent Marine Sponge of the Genus Aaptos‏ ‎‡9 1‏
919 ‎‡a antiviralresistancesurveillanceforinfluenzaavirusinbrazilinvestigationon2009pandemicinfluenzaa‏ ‎‡A Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A‏ ‎‡9 1‏
919 ‎‡a antiviralresistancesurveillanceforinfluenzaavirusinbrazilinvestigationon2009pandemicinfluenzaah1n1resistancetooseltamivir‏ ‎‡A Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A (H1N1) resistance to oseltamivir.‏ ‎‡9 1‏
919 ‎‡a atazanaviraloneorincombinationwithritonavirinhibitssarscov2replicationandproinflammatorycytokineproduction‏ ‎‡A Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production‏ ‎‡9 1‏
919 ‎‡a atazanavirinhibitssarscov2replicationandproinflammatorycytokineproduction‏ ‎‡A Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production‏ ‎‡9 1‏
919 ‎‡a aureonitolafungiderivedtetrahydrofuraninhibitsinfluenzareplicationbytargetingitssurfaceglycoproteinhemagglutinin‏ ‎‡A Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin‏ ‎‡9 1‏
919 ‎‡a capturingsequencediversityinmetagenomeswithcomprehensiveandscalableprobedesign‏ ‎‡A Capturing sequence diversity in metagenomes with comprehensive and scalable probe design‏ ‎‡9 1‏
919 ‎‡a characterizationofhiv1enzymereversetranscriptaseinhibitionbythecompound6chloro14dihydro4oxo1beta500ribofuranosylquinoline3carboxylicacidthroughkineticandinsilicostudies‏ ‎‡A Characterization of HIV-1 enzyme reverse transcriptase inhibition by the compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid through kinetic and in silico studies‏ ‎‡9 1‏
919 ‎‡a clinicalmanifestationsofzikavirusinfectionriodejaneirobrazil‏ ‎‡A Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil, 2015‏ ‎‡9 1‏
919 ‎‡a combinationofantiviraldrugsinhibitssarscov2polymeraseandexonucleaseanddemonstratescovid19therapeuticpotentialinviralcellculture‏ ‎‡A Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture‏ ‎‡9 1‏
919 ‎‡a correctionaureonitolafungiderivedtetrahydrofuraninhibitsinfluenzareplicationbytargetingitssurfaceglycoproteinhemagglutinin‏ ‎‡A Correction: Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin‏ ‎‡9 1‏
919 ‎‡a corrigendumtheclinicallyapprovedantiviraldrugsofosbuvirinhibitszikavirusreplication‏ ‎‡A Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication‏ ‎‡9 1‏
919 ‎‡a detectionofoseltamivirresistantpandemicinfluenzaah1n1pdm2009inbrazilcancommunitytransmissionberuledout‏ ‎‡A Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out?‏ ‎‡9 1‏
919 ‎‡a detectionoftheinfluenzaah1n1pdm09viruscarryingthek15ep83sandq293hmutationsinpatientswhohaveundergonebonemarrowtransplant‏ ‎‡A Detection of the influenza A(H1N1)pdm09 virus carrying the K-15E, P83S and Q293H mutations in patients who have undergone bone marrow transplant‏ ‎‡9 1‏
919 ‎‡a detectionofzikavirusinapril2013patientsamplesriodejaneirobrazil‏ ‎‡A Detection of Zika Virus in April 2013 Patient Samples, Rio de Janeiro, Brazil‏ ‎‡9 1‏
919 ‎‡a developmentofstandardmethodsforzikaviruspropagationtitrationandpurification‏ ‎‡A Development of standard methods for Zika virus propagation, titration, and purification‏ ‎‡9 1‏
919 ‎‡a differentialsheddingandantibodykineticsofzikaandchikungunyavirusesbrazil‏ ‎‡A Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil‏ ‎‡9 1‏
919 ‎‡a h1n1pdminfluenzainfectioninhospitalizedcancerpatientsclinicalevolutionandviralanalysis‏ ‎‡A H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis‏ ‎‡9 1‏
919 ‎‡a h1n1pdm09adjuvantedvaccinationinhivinfectedadultsarandomizedtrialof2singleversus2doubledoses‏ ‎‡A H1N1pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two single versus two double doses.‏ ‎‡9 1‏
919 ‎‡a herpessimplextype1activatesglycolysisthroughengagementoftheenzyme6phosphofructo1kinase‏ ‎‡A Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase‏ ‎‡9 1‏
919 ‎‡a herpessimplextype1activatesglycolysisthroughengagementoftheenzyme6phosphofructo1kinasepfk1‏ ‎‡A Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase (PFK-1).‏ ‎‡9 1‏
919 ‎‡a hiv1anditsgp120inhibitstheinfluenzaah1n1pdm09lifecycleinanifitm3dependentfashion‏ ‎‡A HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion‏ ‎‡9 1‏
919 ‎‡a hivcontrollerssuppressviralreplicationandevolutionandpreventdiseaseprogressionfollowingintersubtypehiv1superinfection‏ ‎‡A HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection‏ ‎‡9 1‏
919 ‎‡a humanendogenousretroviruskintherespiratorytractisassociatedwithcovid19physiopathology‏ ‎‡A Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology‏ ‎‡9 1‏
919 ‎‡a identificationof1aryl1h123triazolesaspotentialnewantiretroviralagents‏ ‎‡A Identification of 1-Aryl-1H-1,2,3-triazoles as Potential New Antiretroviral Agents‏ ‎‡9 1‏
919 ‎‡a immunogenicityandsustainabilityoftheimmuneresponseinbrazilianhiv1infectedindividualsvaccinatedwithinactivatedtripleinfluenzavaccine‏ ‎‡A Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine‏ ‎‡9 1‏
919 ‎‡a influenzavirusrnapolymerasemaybeactivatedinsidethevirion‏ ‎‡A Influenza virus RNA polymerase may be activated inside the virion‏ ‎‡9 1‏
919 ‎‡a inhibitionofhsv1replicationandhsvdnapolymerasebythechloroxoquinolinicribonucleoside6chloro14dihydro4oxo1beta500ribofuranosylquinoline3carboxylicacidanditsaglycone‏ ‎‡A Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone‏ ‎‡9 1‏
919 ‎‡a inhibitoryeffectofmicroalgaeandcyanobacteriaextractsoninfluenzavirusreplicationandneuraminidaseactivity‏ ‎‡A Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity‏ ‎‡9 1‏
919 ‎‡a intranasalimmunizationwithpressureinactivatedavianinfluenzaelicitscellularandhumoralresponsesinmice‏ ‎‡A Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice‏ ‎‡9 1‏
919 ‎‡a lipiddropletsfuelsarscov2replicationandproductionofinflammatorymediators‏ ‎‡A Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators‏ ‎‡9 1‏
919 ‎‡a molecularfindingsfrominfluenzaa‏ ‎‡A Molecular findings from influenza A‏ ‎‡9 1‏
919 ‎‡a molecularfindingsfrominfluenzaah1n1pdm09detectedinpatientsfromabrazilianequatorialregionduringthepandemicperiod‏ ‎‡A Molecular findings from influenza A(H1N1)pdm09 detected in patients from a Brazilian equatorial region during the pandemic period.‏ ‎‡9 1‏
919 ‎‡a n2arylmethyliminoethyl7chloroquinolin4aminederivativessynthesizedbythermalandultrasonicmeansareendowedwithantizikavirusactivity‏ ‎‡A N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity‏ ‎‡9 1‏
919 ‎‡a newefavirenzderivativesand123triazolylphosphonatesasinhibitorsofreversetranscriptaseofhiv1‏ ‎‡A New efavirenz derivatives and 1,2,3-triazolyl-phosphonates as inhibitors of reverse transcriptase of HIV-1‏ ‎‡9 1‏
919 ‎‡a plateletmonocyteinteractionamplifiesthromboinflammationthroughtissuefactorsignalingincovid19‏ ‎‡A Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19‏ ‎‡9 1‏
919 ‎‡a polymorphismsatresidue222ofthehemagglutininofpandemicinfluenzaah1n1pdm09associationofquasispeciestomorbidityandmortalityindifferentriskcategories‏ ‎‡A Polymorphisms at residue 222 of the hemagglutinin of pandemic influenza A(H1N1)pdm09: association of quasi-species to morbidity and mortality in different risk categories‏ ‎‡9 1‏
919 ‎‡a rapidantigentestsfordenguevirusserotypesandzikavirusinpatientserum‏ ‎‡A Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.‏ ‎‡9 1‏
919 ‎‡a sarofaseriesofantihsv1acridonederivativesandarationalacridonebaseddesignofanewantihsv13hbenzopyrazolo16naphthyridineseries‏ ‎‡A SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine series.‏ ‎‡9 1‏
919 ‎‡a sofosbuvirprotectszikavirusinfectedmicefrommortalitypreventingshortandlongtermsequelae‏ ‎‡A Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae‏ ‎‡9 1‏
919 ‎‡a synthesisandantihsv1activityofnew123triazolederivatives‏ ‎‡A Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives‏ ‎‡9 1‏
919 ‎‡a synthesisandantihsv1evaluationofnew3hbenzopyrazolo16naphthyridinesand3hpyridopyrazolo16naphthyridines‏ ‎‡A Synthesis and anti-HSV-1 evaluation of new 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines and 3H-pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridines‏ ‎‡9 1‏
919 ‎‡a synthesisantiviralactivityandmolecularmodelingofoxoquinolinederivatives‏ ‎‡A Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives‏ ‎‡9 1‏
919 ‎‡a alkaloid4methylaaptamineisolatedfromthespongeaaptosaaptosimpairsherpessimplexvirustype1penetrationandimmediateearlyproteinsynthesis‏ ‎‡A The alkaloid 4-methylaaptamine isolated from the sponge Aaptos aaptos impairs Herpes simplex virus type 1 penetration and immediate-early protein synthesis‏ ‎‡9 1‏
919 ‎‡a clinicallyapprovedantiviraldrugsofosbuvirinhibitszikavirusreplication‏ ‎‡A The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication‏ ‎‡9 1‏
919 ‎‡a compound6chloro14dihydro4oxo1beta500ribofuranosylquinoline3carboxylicacidinhibitshiv1replicationbytargetingtheenzymereversetranscriptase‏ ‎‡A The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase‏ ‎‡9 1‏
919 ‎‡a dolabellanediterpenedolabelladienetriolisatypicalnoncompetitiveinhibitorofhiv1reversetranscriptaseenzyme‏ ‎‡A The dolabellane diterpene Dolabelladienetriol is a typical noncompetitive inhibitor of HIV-1 reverse transcriptase enzyme‏ ‎‡9 1‏
919 ‎‡a effectsofneurotrophinsandtheneuropeptidesvipandpacaponhiv1infectionhistorieswithoppositeends‏ ‎‡A The effects of neurotrophins and the neuropeptides VIP and PACAP on HIV-1 infection: histories with opposite ends‏ ‎‡9 1‏
919 ‎‡a nervegrowthfactorreducesapobec3gsynthesisandenhanceshiv1transcriptionandreplicationinhumanprimarymacrophages‏ ‎‡A The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages.‏ ‎‡9 1‏
919 ‎‡a yellowfevervirusissusceptibletosofosbuvirbothinvitroandinvivo‏ ‎‡A Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2015‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000043481079‏
996 ‎‡2 BLBNB|000400261‏
996 ‎‡2 BLBNB|001462785‏
996 ‎‡2 LC|no2020133938‏
996 ‎‡2 BLBNB|000867840‏
996 ‎‡2 PTBNP|316914‏
996 ‎‡2 DNB|1241968187‏
996 ‎‡2 DNB|1254629513‏
996 ‎‡2 LC|n 2009220451‏
996 ‎‡2 ISNI|0000000072813626‏
996 ‎‡2 SIMACOB|305828707‏
996 ‎‡2 DNB|1273590406‏
996 ‎‡2 BLBNB|000471663‏
996 ‎‡2 PTBNP|1912572‏
996 ‎‡2 PTBNP|1928315‏
996 ‎‡2 BLBNB|001474653‏
996 ‎‡2 ISNI|0000000039611918‏
996 ‎‡2 PLWABN|9810688833305606‏
996 ‎‡2 ISNI|0000000501169008‏
996 ‎‡2 LC|no2017103121‏
996 ‎‡2 NTA|075139723‏
996 ‎‡2 BLBNB|001455864‏
996 ‎‡2 BLBNB|001572338‏
996 ‎‡2 SUDOC|233742654‏
996 ‎‡2 DNB|142424110‏
996 ‎‡2 LC|nb2005013633‏
996 ‎‡2 BLBNB|000343907‏
996 ‎‡2 BLBNB|001579259‏
996 ‎‡2 ISNI|0000000420140019‏
996 ‎‡2 LC|no2023100790‏
996 ‎‡2 BLBNB|001416826‏
996 ‎‡2 DNB|1156299934‏
996 ‎‡2 ISNI|0000000400270246‏
996 ‎‡2 DNB|115899110X‏
996 ‎‡2 BLBNB|000293188‏
996 ‎‡2 DNB|116329795X‏
996 ‎‡2 BLBNB|001525783‏
996 ‎‡2 BLBNB|001011797‏
996 ‎‡2 BLBNB|000998296‏
996 ‎‡2 DNB|1215511205‏
996 ‎‡2 NII|DA04009415‏
996 ‎‡2 PLWABN|9811988361405606‏
996 ‎‡2 BIBSYS|1535375966588‏
996 ‎‡2 LC|no2020010995‏
996 ‎‡2 PLWABN|9811239865405606‏
996 ‎‡2 LC|n 2013201782‏
996 ‎‡2 ISNI|0000000486501470‏
996 ‎‡2 ISNI|0000000070536872‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏